The Global Parkinson’s Genetics Program (GP2) is a project designed to understand the architecture of Parkinson’s disease (PD). Dr. Sarah Camargos sits down with Dr. Andrew Singleton to discuss GP2 and its initiative to increase our global understanding of PD and in doing so, better understand the genetic landscape of underrepresented populations.